Medications for Multiple Myeloma
62 results
Abecma (idecabtagene vicleucel)
(idecabtagene vicleucel)Celgene Corporation
Usage: ABECMA is indicated for adult patients with relapsed or refractory multiple myeloma after two or more prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. It is a genetically modified autologous T cell immunotherapy targeting B-cell maturation antigen (BCMA).
Aphexda (motixafortide)
(Motixafortide)BioLineRx USA Inc
Usage: APHEXDA is indicated for use with filgrastim (G-CSF) to mobilize hematopoietic stem cells into the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.
Bortezomib (bortezomib)
(Bortezomib)Novadoz Pharmaceuticals LLC
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(Bortezomib)Accord Healthcare Inc.
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(BORTEZOMIB)Hospira, Inc.
Usage: Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(bortezomib)Hikma Pharmaceuticals USA Inc.
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(Bortezomib)NorthStar RxLLC
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Boruzu (bortezomib)
(Bortezomib)Amneal Pharmaceuticals LLC
Usage: BORUZU is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Carmustine (carmustine)
(CARMUSTINE)Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Carmustine for Injection, USP is indicated for palliative therapy as a single agent or in combination therapy for brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).
Carmustine (carmustine)
(CARMUSTINE)Sandoz Inc.
Usage: Carmustine for injection is indicated for palliative therapy as a single agent or in combination for brain tumors, multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).
- ...